ReviewFrontiers in immunology2024

Overcoming limitations for antibody-based therapies targeting γδ T (Vg9Vd2) cells.

Lucía Paniagua-Herranz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.